Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial

Effect of Albumin on Diuretic Response to Furosemide in Patients With Hypoalbuminemia

(2012) T. Doungngern et al.   AMERICAN JOURNAL OF CRITICAL CARE

Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema

(2012) Elsa Solà et al.   JOURNAL OF HEPATOLOGY

Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia

(2012) Shahid Habib et al.   Therapeutic Advances in Gastroenterology

Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH)

(2011) Natig Gassanov et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Management of ascites in cirrhosis

(2011) Florence Wong   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

(2010)   JOURNAL OF HEPATOLOGY

Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome

(2009) Rajmohan Dharmaraj et al.   PEDIATRIC NEPHROLOGY

Liver cirrhosis

(2008) Detlef Schuppan et al.   LANCET

Non-peptide arginine-vasopressin antagonists: the vaptans

(2008) Guy Decaux et al.   LANCET

Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List

(2008) W. Ray Kim et al.   NEW ENGLAND JOURNAL OF MEDICINE